Form P.s.1 Instructions - 2012 Page 3

ADVERTISEMENT

Line 25: Medical Device Credit. For tax years beginning on or after
Line 29: Life Sciences Company Research Credit. For taxable years
January 1, 2006, medical device companies that develop or manufac-
beginning on or after January 1, 2009, a new credit may be available
ture medical devices in Massachusetts can claim a credit equal to
for certified life sciences companies pursuant to the Life Sciences Tax
100% of the user fees paid to the U. S. Food and Drug Administration.
Incentive Program, to provide qualifying companies with a means to
The credit is transferable. For more information, see TIR 06-22.
obtain a research credit for certain expenditures not qualifying for the
existing research credit under c. 63, § 38M. St. 2008, c. 130, §§ 30 and
Line 26: Brownfields Credit. Recent legislation extends the Browns-
53, codified at G.L. c. 63, § 38W. Under this new provision, the credit is
field credit to nonprofit organizations, extends the time frame for eligibil-
generally calculated in the same manner as the research credit under
ity for the credit, and permits the credit to be bought, sold or assigned.
section 38M. However, the qualified research expenditures which form
Under prior law, net response and removal costs incurred by a tax-
payer between August 1, 1998 and August 5, 2005, were eligible for
the basis for the calculation in new section 38W differ from those of
the credit provided that the taxpayer commenced and diligently pur-
section 38M in that they can qualify when the activities are performed
sued an environmental response action before August 5, 2005. As a
both inside and outside of the Commonwealth, to the extent they relate
result of the recent legislation, the environmental response action com-
to legally mandated clinical trial activities. The new life sciences re-
mencement cut-off date is changed from August 5, 2005 to August 5,
search credit is not refundable. For further information, see TIR 08-23.
2013, and the time for incurring eligible costs that qualify for the credit
Line 32: Voluntary Contribution for Endangered Wildlife Conser-
is extended to January 1, 2014. For further information, see TIR 06-16.
vation. Any corporation that wishes to contribute any amount to the
Line 27: Life Science Company Investment Tax Credit. For taxable
Natural Heritage and Endangered Species Fund may do so on this
years beginning on or after January 1, 2009, a new Investment Tax
form. This amount is added to the excise due. It increases the amount
Credit (ITC) may be available to taxpayers.
of the corporation’s payment or reduces the amount of its refund.
This credit, which is available to certified life sciences companies only
The Natural Heritage and Endangered Species Fund is administered
to the extent authorized pursuant to the Life Sciences Tax Incentive
by the Department of Fisheries, Wildlife and Law Enforcement to pro-
Program, is equal to 10% of the cost of qualifying property acquired,
vide for conservation programs for rare, endangered and nongame
constructed or erected during the taxable year and used exclusively
wildlife and plants in the Commonwealth.
in the Commonwealth.
Line 37: Pass-through Entity Withholding. Enter the amount of any
The refundable ITC can apply to purchases made on or after January
withholding tax from pass-through entities. Be sure to include the tax-
1, 2009 even if a construction project started before that date. The
payer identification number of the person or entity submitting the with-
scope of qualifying property for purposes of the new credit is the same
holding payment on behalf of the taxpayer.
as that provided by the existing ITC under M.G.L. Ch. 63, sec. 31A.
Line 38: Refundable Film Credit. Schedule RFC, Refundable Film
Life sciences companies or persons also qualifying for the Economic
Credit, is used by motion picture production companies to elect to claim
Opportunity Area Credit (EOAC) for the same property may only take
a refundable film credit if they have not transferred or carried forward a
such EOAC to the extent of an additional 2% of the cost of the qualify-
portion of the film credit for the production. Transferees of the film credit
ing property. Corporations taking these credits are not allowed to take
do not qualify for the refundable film credit. If an election to refund the
the ITC under M.G.L. Ch. 63, sec. 31A or the Low-Income Housing
film credit for a production is made, the entire film credit remaining after
Credit under M.G.L. Ch. 63, sec. 31H for the same qualifying property.
reducing the current year tax liability will be refunded at 90%. The pro-
duction company is not allowed to partially refund and partially trans-
If a life sciences ITC exceeds the tax otherwise due as applicable,
fer or carryover over any portion of the credit to the next tax year.
90% of the balance of such credit may, at the option of the taxpayer
and to the extent authorized pursuant to the Life Sciences Tax Incen-
Line 39: Refundable Dairy Credit. A taxpayer who holds a certificate
tive Program, be refundable to the taxpayer for the tax year in which
of registration as a dairy farmer pursuant to M.G.L. Ch. 94, sec. 16A
the qualified property giving rise to such credit is placed in service. If
is allowed a refundable tax credit based on the amount of milk pro-
such refund is elected by the taxpayer, then the carryover provisions
duced and sold. The dairy farmer tax credit as originally enacted was
for this credit that would otherwise apply shall not be available. For fur-
90% refundable. Under recent legislation, the dairy farmer tax credit
ther information, see TIR 08-23.
is now 100% refundable.
Line 28: Life Science Company FDA User Fees Credit. For taxable
Line 40: Refundable Life Science Credit. There are two different
years beginning on or after January 1, 2009, a new credit may be
credits which the Massachusetts Life Sciences Center, with the ap-
available to taxpayers for user fees paid on or after June 16, 2008 to
proval of the Secretary of Administration and Finance, may authorize
the U.S. Food and Drug Administration (USFDA) upon submission of
a taxpayer to have refunded in lieu of carrying forward such credit to
an application to manufacture a human drug in the Commonwealth.
a future year.
This credit, which is available to certified life sciences companies only
A taxpayer may apply for a refund of 90% of the unused Investment
to the extent authorized pursuant to the Life Sciences Tax Incentive
Tax Credit granted under M.G.L. Ch. 63, sec. 38U or the additional
Program, is equal to 100% of the user fees actually paid by the tax-
credit on the same property that may be granted under M.G.L. Ch.
payer, as specified in the certification, and may be claimed in the tax-
63, sec. 38N if property for which the 38U credit is granted is used in
able year in which the application for licensure of an establishment to
a certified project.
manufacture the drug is approved by the USFDA.
A taxpayer may apply for a refund of 90% of the unused FDA User
To be eligible for the credit, more than 50% of the research and de-
Fee Credit granted under M.G.L. Ch. 63, sec. 38M, including credits
velopment costs for the drug must have been incurred in Massachu-
carried over from prior years. Schedule RLC, Refundable Life Science
setts. Taxpayers may use the FDA user fees credit to reduce their tax
Credit, is used by taxpayers to claim the refund.
to zero. To the extent authorized pursuant to the Life Sciences Tax In-
Line 41: Refundable Life Science Jobs Credit. Effective for tax years
centive Program, 90% of the balance of credit remaining is refund-
beginning on or after January 1, 2011, a new tax incentive has been
able. The deduction otherwise allowable for user fees qualifying for
added to the Life Sciences Tax Incentive Program in the form of a re-
the credit is disallowed. For further information, see TIR 08-23.
fundable jobs credit. A taxpayer, to the extent authorized by the Life
Sciences Tax Incentive Program, may be allowed a refundable jobs
3

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Financial
Go
Page of 5